2009
DOI: 10.2174/138955709788681654
|View full text |Cite
|
Sign up to set email alerts
|

Cellular Efflux of cAMP and cGMP - A Question about Selectivity

Abstract: The present paper reviews and discusses selectivity of ABCC4 (MRP4), ABCC5 (MRP5) and ABCC11 (MRP8) as cellular efflux pumps for cAMP and cGMP. These transporters are potential drug targets for selective modulation of cyclic nucleotide action.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
23
0

Year Published

2011
2011
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 38 publications
(26 citation statements)
references
References 51 publications
3
23
0
Order By: Relevance
“…Under physiological conditions, cytosolic cGMP may be secreted through nucleotide transporters such as CFTR and multidrug resistance proteins (60,61). In human plasma, the cGMP level is 6 nM (62).…”
Section: Discussionmentioning
confidence: 99%
“…Under physiological conditions, cytosolic cGMP may be secreted through nucleotide transporters such as CFTR and multidrug resistance proteins (60,61). In human plasma, the cGMP level is 6 nM (62).…”
Section: Discussionmentioning
confidence: 99%
“…Because mammalian ABCC5 transports cyclic nucleotides (Jedlitschky et al, 2000;Sager and Ravna, 2009;Wielinga et al, 2003), and there is evidence for cAMP signaling in C5a-expressing pigment cells (i.e. expression of Sp-CAPK/PKA; Rast et al, 2002), we tested whether there is a link between cyclic nucleotide signaling and C5a.…”
Section: C5a-mediated Prolapse Is Rescued By Campmentioning
confidence: 99%
“…A number of studies have shown that mammalian ABCC5 transports cyclic nucleotides (Boadu and Sager, 2004;Jedlitschky et al, 2000;Meyer Zu Schwabedissen et al, 2005;Sager and Ravna, 2009;Sager et al, 2012;Wielinga et al, 2003;Wijnholds et al, 2000). cGMP is reported to be a higher-affinity substrate than cAMP, but the exact affinity of cGMP remains unclear Pratt et al, 2005;Reid et al, 2003;Wielinga et al, 2003).…”
Section: Substrates Of C5amentioning
confidence: 99%
See 1 more Smart Citation
“…Extracellular adenosine, in turn, can interact with one or more G-protein-coupled P1 receptors [18] or can be taken back up into cells via ENT (equilibrative nucleoside transporter [19]) to undergo metabolic fates that include the synthesis of ATP. One consequence of the activation of P1 (and certain P2Y) receptors is a change in cellular levels of cAMP, which can exit cells by certain multidrug resistant proteins (MRPs 4 and 5; [20]). The conversion of extracellular cAMP to AMP by D. discoidium occurs via extracellular phosphodiesterases [21].…”
Section: Introductionmentioning
confidence: 99%